Cargando…
Peroxiredoxin 2: a potential biomarker for early diagnosis of Hepatitis B Virus related liver fibrosis identified by proteomic analysis of the plasma
BACKGROUND: Liver fibrosis is a middle stage in the course of chronic Hepatitis B virus (HBV) infection, which will develop into cirrhosis and eventually hepatocellular carcinoma (HCC) if not treated at the early stage. Considering the limitations and patients' reluctance to undergo liver biops...
Autores principales: | Lu, Ye, Liu, Jie, Lin, Chengzhao, Wang, Haijian, Jiang, Ying, Wang, Jiyao, Yang, Pengyuan, He, Fuchu |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959091/ https://www.ncbi.nlm.nih.gov/pubmed/20939925 http://dx.doi.org/10.1186/1471-230X-10-115 |
Ejemplares similares
-
Regular Patterns for Proteome-Wide Distribution of Protein Abundance across Species
por: Zhong, Fan, et al.
Publicado: (2012) -
Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human Abdominal Aortic Aneurysm
por: Burillo, Elena, et al.
Publicado: (2016) -
Plasma biomarker screening for liver fibrosis with the N-terminal isotope tagging strategy
por: Li, ShuLong, et al.
Publicado: (2011) -
Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis
por: Jiang, Yan, et al.
Publicado: (2021) -
SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH
por: Luo, Yi, et al.
Publicado: (2021)